Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,087	2,110	2,515	1,633	1,524	1,108
Market Cap Growth	59.74%	-16.09%	54.03%	7.15%	37.56%	-10.17%
Enterprise Value	3,020	1,971	2,278	1,438	1,396	963.61
Last Close Price	6.72	5.34	7.00	5.58	7.10	6.71
Forward PE	-	22.61	5.66	5.66	5.66	5.66
PS Ratio	48.93	33.82	54.55	28.34	67.42	29.00
PB Ratio	12.42	6.23	5.10	2.99	3.01	2.10
P/TBV Ratio	-	-	25.63	10.63	14.37	10.43
EV/Sales Ratio	47.86	31.58	49.41	24.96	61.76	25.23
Debt / Equity Ratio	0.15	0.13	0.17	0.19	0	0
Net Debt / Equity Ratio	-0.29	-0.41	-0.48	-0.36	-0.25	-0.27
Net Debt / EBITDA Ratio	0.20	0.41	0.72	0.60	0.65	1.36
Net Debt / FCF Ratio	0.27	0.52	1.04	0.70	0.74	1.11
Asset Turnover	0.11	0.09	0.06	0.09	0.04	0.06
Inventory Turnover	26.44	30.30	13.65	16.92	9.69	4.12
Quick Ratio	0.65	1.01	1.83	3.27	2.79	3.85
Current Ratio	0.69	1.05	1.86	3.33	2.98	3.90
Return on Equity (ROE)	-86.67%	-82.18%	-66.04%	-62.16%	-37.51%	-18.05%
Return on Assets (ROA)	-62.53%	-47.44%	-42.40%	-49.15%	-35.05%	-16.43%
Return on Invested Capital (ROIC)	-195.75%	-149.07%	-108.44%	-89.03%	-52.03%	-29.12%
Return on Capital Employed (ROCE)	-105.38%	-68.92%	-52.94%	-55.62%	-38.03%	-17.96%
Buyback Yield / Dilution	-16.70%	-20.10%	-19.57%	-33.86%	-7.97%	-166.96%
Total Shareholder Return	-16.70%	-20.10%	-19.57%	-33.86%	-7.97%	-166.96%